313 related articles for article (PubMed ID: 19167427)
21. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
22. Gonadal steroids block the calpain-1-dependent intrinsic pathway of apoptosis in an experimental rat stroke model.
Vahidinia Z; Alipour N; Atlasi MA; Naderian H; Beyer C; Azami Tameh A
Neurol Res; 2017 Jan; 39(1):54-64. PubMed ID: 27832728
[TBL] [Abstract][Full Text] [Related]
23. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques.
Türeyen K; Vemuganti R; Sailor KA; Dempsey RJ
J Neurosci Methods; 2004 Oct; 139(2):203-7. PubMed ID: 15488233
[TBL] [Abstract][Full Text] [Related]
24. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts.
Joshi CN; Jain SK; Murthy PS
Brain Res Brain Res Protoc; 2004 Apr; 13(1):11-7. PubMed ID: 15063836
[TBL] [Abstract][Full Text] [Related]
25. Localizing coordinates of cerebral ischemic tissue without the need of staining in a rat model of focal cerebral infarct.
Ruiz-Crespo S; Trejo-Gabriel-Galán JM; Coma-del-Corral MJ
Metab Brain Dis; 2013 Mar; 28(1):21-4. PubMed ID: 23160835
[TBL] [Abstract][Full Text] [Related]
26. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses.
Kramer M; Dang J; Baertling F; Denecke B; Clarner T; Kirsch C; Beyer C; Kipp M
J Neurosci Methods; 2010 Mar; 187(1):84-9. PubMed ID: 20064557
[TBL] [Abstract][Full Text] [Related]
27. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats.
Li F; Omae T; Fisher M
Stroke; 1999 Nov; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685
[TBL] [Abstract][Full Text] [Related]
29. Mouse model of middle cerebral artery occlusion.
Chiang T; Messing RO; Chou WH
J Vis Exp; 2011 Feb; (48):. PubMed ID: 21372780
[TBL] [Abstract][Full Text] [Related]
30. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats.
Glendenning ML; Lovekamp-Swan T; Schreihofer DA
Neurosci Lett; 2008 Nov; 445(2):188-92. PubMed ID: 18790008
[TBL] [Abstract][Full Text] [Related]
32. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.
Schmued LC; Hopkins KJ
Brain Res; 2000 Aug; 874(2):123-30. PubMed ID: 10960596
[TBL] [Abstract][Full Text] [Related]
33. Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes.
Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Seifu S; McAleer J; Willing A; Cuevas J
Neurobiol Dis; 2014 Feb; 62():354-64. PubMed ID: 24141021
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of plasma kallikrein protects brain from reperfusion injury.
Storini C; Bergamaschini L; Gesuete R; Rossi E; Maiocchi D; De Simoni MG
J Pharmacol Exp Ther; 2006 Aug; 318(2):849-54. PubMed ID: 16705080
[TBL] [Abstract][Full Text] [Related]
35. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice.
Duckworth EA; Butler T; Collier L; Collier S; Pennypacker KR
Brain Res; 2006 May; 1088(1):167-75. PubMed ID: 16630592
[TBL] [Abstract][Full Text] [Related]
36. Histopathological effects of delayed reperfusion after middle cerebral artery occlusion in the anesthetized baboon.
Giffard C; Young AR; Mézenge F; Derlon JM; Baron JC
Brain Res Bull; 2005 Oct; 67(4):335-40. PubMed ID: 16182942
[TBL] [Abstract][Full Text] [Related]
37. Yonkenafil: a novel phosphodiesterase type 5 inhibitor induces neuronal network potentiation by a cGMP-dependent Nogo-R axis in acute experimental stroke.
Chen X; Wang N; Liu Y; Liu Y; Zhang T; Zhu L; Wang Y; Wu C; Yang J
Exp Neurol; 2014 Nov; 261():267-77. PubMed ID: 25064698
[TBL] [Abstract][Full Text] [Related]
38. An improved automated method to quantitate infarct volume in triphenyltetrazolium stained rat brain sections.
Regan HK; Detwiler TJ; Huang JC; Lynch JJ; Regan CP
J Pharmacol Toxicol Methods; 2007; 56(3):339-43. PubMed ID: 17596972
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotection by Exogenous and Endogenous Neuregulin-1 in Mouse Models of Focal Ischemic Stroke.
Noll JM; Li Y; Distel TJ; Ford GD; Ford BD
J Mol Neurosci; 2019 Oct; 69(2):333-342. PubMed ID: 31290093
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effect of chondroitinase ABC on primary and secondary brain injury after stroke in hypertensive rats.
Chen XR; Liao SJ; Ye LX; Gong Q; Ding Q; Zeng JS; Yu J
Brain Res; 2014 Jan; 1543():324-33. PubMed ID: 24326094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
